Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1372407

COC(=O)CCC(=O)O.Cl

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 1/20 0.43
HDAC3 known ✓ O15379 1/20 0.41
HDAC1 known ✓ Q13547 1/20 0.41
HDAC2 known ✓ Q92769 1/20 0.41
HDAC8 known ✓ Q9BY41 1/20 0.41
TSHR P16473 4/20 0.72
LMNA P02545 5/20 0.56
KDM4E B2RXH2 5/20 0.56
EGLN1 Q9GZT9 5/20 0.52
KDM5C P41229 4/20 0.52
PHF8 Q9UPP1 4/20 0.52
KDM2A Q9Y2K7 4/20 0.52
KDM6B O15054 3/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
ALKBH5 Q6P6C2 1/20 0.50
SUCNR1 Q9BXA5 1/20 0.50
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28270066 0.97 TSHR (0.77) TSHRLMNAKDM4EEGLN1KDM5C
Succinic Acid SCHEMBL18063898 0.97 TSHR (0.77) TSHRLMNAKDM4EEGLN1KDM5C
Dimethyl Succinate SCHEMBL28154694 0.97 TSHR (0.77) TSHRLMNAKDM4EEGLN1KDM5C
Dimethyl Succinate SCHEMBL20335703 0.97 TSHR (0.77) TSHRLMNAKDM4EEGLN1KDM5C
SCHEMBL164072 0.97
Dimethyl Succinate SCHEMBL28606769 0.97 TSHR (0.77) TSHRLMNAKDM4EEGLN1KDM5C
Dimethyl Succinate SCHEMBL29626086 0.97 TSHR (0.77) TSHRLMNAKDM4EEGLN1KDM5C
SCHEMBL11672392 0.94 TSHR (0.72) TSHRLMNAKDM4EEGLN1KDM5C
SCHEMBL6396564 0.94 TSHR (0.72) TSHRLMNAKDM4EEGLN1KDM5C
Ammonia Solution, Strong SCHEMBL17600636 0.94 TSHR (0.72) TSHRLMNAKDM4EEGLN1KDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024160593-A1 PROCESS FOR PURIFYING 2-PHENYL-4-(3-CARBOALKOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE AND NEW CRYSTALLINE FORM B OF 2-PHENYL-4-(3-CARBOMETHOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2024-08-08 WO claimed
EP-4410778-A1 PROCESS FOR THE PURIFICATION OF 2-PHENYL-4-(3-CARBOALKOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE AND NEW CRYSTALLINE FORM B OF 2-PHENYL-4-(3-CARBOMETHOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE Heraeus Precious Metals GmbH & Co. KG (DE) 2024-08-07 EP claimed
CN-110723910-B Cell culture material for controlling cell adhesion and cell detachment and preparation method thereof 东南大学 2021-12-07 CN claimed
CN-110723910-A Cell culture material for controlling cell adhesion and cell detachment and preparation method thereof 东南大学 2020-01-24 CN claimed
CN-122055150-A Cyproheptadine derivatives 思凯生科股份有限公司 2026-05-15 CN disclosed
CN-115845152-B Medical apparatus and instruments 元心科技(深圳)有限公司 2024-12-13 CN disclosed
WO-2024160593-A1 PROCESS FOR PURIFYING 2-PHENYL-4-(3-CARBOALKOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE AND NEW CRYSTALLINE FORM B OF 2-PHENYL-4-(3-CARBOMETHOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2024-08-08 WO disclosed
EP-4410778-A1 PROCESS FOR THE PURIFICATION OF 2-PHENYL-4-(3-CARBOALKOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE AND NEW CRYSTALLINE FORM B OF 2-PHENYL-4-(3-CARBOMETHOXYPROPIONYL)-1,3-OXAZOLIN-5-ONE Heraeus Precious Metals GmbH & Co. KG (DE) 2024-08-07 EP disclosed
CN-117863679-A Manufacturing process of polyethylene non-woven fabric high-water-pressure-resistance fabric 华懋(厦门)特种材料有限公司 2024-04-12 CN disclosed
CN-117720466-A 2 '-acetyl-2', 3 '-dihydro-4'H-spiro [ cyclohexane-1, 1 '-isoquinoline ] -4' -ketone compound and preparation method and application thereof 承德医学院 2024-03-19 CN disclosed
CN-117229215-A Biaryl compound, pharmaceutical composition containing biaryl compound, preparation method and application of biaryl compound 四川科伦博泰生物医药股份有限公司 2023-12-15 CN disclosed
CN-114096525-B Biaryl compound, pharmaceutical composition containing biaryl compound, preparation method and application of biaryl compound 四川科伦博泰生物医药股份有限公司 2023-10-13 CN disclosed
US-4265892-A Cephalosporins having an α-acylaminoacetic acid side chain CIBA-GEIGY CORPORATION (US) 1981-05-05 US disclosed
US-4162314-A ANTIBIOTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1979-07-24 US disclosed
US-4154831-A Cephalosporins having an α-acylaminoacetic acid side chain CIBA-GEIGY CORPORATION (US) 1979-05-15 US disclosed
US-4137323-A 4-OXO-4H-BENZO(4,5)CYCLOHEPTA(1,2-B)THIOPHEN-2-YL-OXOALKANOIC ACIDS AND ESTERS, ANTIARTHRITICS, ANTIEDEMICS AND ANTIPHLOGISTICS SANDOZ LTD. (CH) 1979-01-30 US disclosed
US-4052412-A ANTIPHLOGISTIC, ANTIARTHRITIC SANDOZ LTD. (CH) 1977-10-04 US disclosed
US-4041161-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1977-08-09 US disclosed
US-4036877-A Process for the production of aldehydes BUDAPESTI MUSZAKI EGYETEM (HU) 1977-07-19 US disclosed
US-4025501-A Polypeptide propoxyphene derivatives for immunoassay reagents SYVA COMPANY (US) 1977-05-24 US disclosed